1. Evaluation of Patients With Hepatocellular Carcinomas That Do Not Produce α-Fetoprotein
- Author
-
Agopian, Vatche G, Harlander-Locke, Michael P, Markovic, Daniela, Zarrinpar, Ali, Kaldas, Fady M, Cheng, Elaine Y, Yersiz, Hasan, Farmer, Douglas G, Hiatt, Jonathan R, and Busuttil, Ronald W
- Subjects
Digestive Diseases ,Rare Diseases ,Transplantation ,Liver Disease ,Organ Transplantation ,Cancer ,Liver Cancer ,Adult ,Carcinoma ,Hepatocellular ,Disease-Free Survival ,Female ,Humans ,Liver Neoplasms ,Liver Transplantation ,Male ,Microvessels ,Neoplasm Grading ,Neoplasm Invasiveness ,Neoplasm Recurrence ,Local ,Neoplasm Staging ,Retrospective Studies ,Tumor Burden ,alpha-Fetoproteins - Abstract
ImportanceSerum α-fetoprotein (AFP) is a biomarker for hepatocellular carcinomas (HCCs) associated with a more aggressive tumor phenotype and inferior outcomes after a liver transplant (LT). Data on the outcomes for patients with HCCs that do not produce AFP are limited.ObjectiveTo compare characteristics and outcomes among LT recipients with radiographically apparent HCC lesions with AFP-producing tumors or with tumors that do not produce AFP (hereafter referred to as non-AFP-producing tumors), and to identify factors influencing recurrence in LT recipients with non-AFP-producing tumors.Design, setting, and participantsRetrospective analysis at a university transplant center of 665 adults with HCC who underwent an LT during the period from 1989 to 2013. Of the 665 LT recipients, 457 (68.7%) had AFP-producing tumors, and 208 (31.3%) had non-AFP-producing tumors (the maximum AFP level before an LT was ≤10 ng/mL). Dates of study analysis were from August 2015 to June 2016.InterventionLiver transplant.Main outcomes and measuresRecurrence-free survival and recurrence rates.ResultsPatients with non-AFP-producing tumors had radiographic tumor characteristics similar to those of patients with AFP-producing tumors, but, pathologically, they had fewer lesions (25% vs 35% with >2 lesions; P = .03), smaller cumulative tumor diameters (4.2 vs 5.0 cm; P = .02), fewer microvascular (17% vs 22%) and macrovascular (2% vs 9%) invasions (P 2 tumors [HR, 4.98; 95% CI, 1.72-14.4; P = .003]; cumulative diameter [1.70 per log SD; 1.12-2.59; P 2 tumors [4.39; 1.32-14.6; P = .02]; cumulative diameter [2.32 per log SD; 1.43-3.77; P = .001]; microvascular [3.07; 1.02-9.24; P = .05] and macrovascular invasion [8.75; 2.15-35.6; P = .002]).Conclusions and relevanceNearly one-third of patients with radiographically apparent HCC have non-AFP-producing tumors that have more favorable pathologic characteristics, lower posttransplant recurrence, and superior survival compared with patients with AFP-producing tumors. Posttransplant HCC recurrence for patients with non-AFP-producing tumors is predicted by important radiologic and pathologic factors, and is negligible for patients within the Milan criteria. Stratifying patients by AFP status in addition to radiological criteria may improve the selection process for and the prioritization of transplant candidates.
- Published
- 2017